Imbalanced turnover of collagen type III is associated with disease progression and mortality in high-risk chronic kidney disease patients
出版年份 2019 全文链接
标题
Imbalanced turnover of collagen type III is associated with disease progression and mortality in high-risk chronic kidney disease patients
作者
关键词
-
出版物
Clinical Kidney Journal
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2019-11-18
DOI
10.1093/ckj/sfz174
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Serological markers of extracellular matrix remodeling predict transplant-free survival in primary sclerosing cholangitis
- (2018) M. J. Nielsen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Stephen A Harrison et al. LANCET
- Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening
- (2018) Patrick Marcellin et al. LIVER INTERNATIONAL
- Non-invasive quantification of collagen turnover in renal transplant recipients
- (2017) Elisabeth G. D. Stribos et al. PLoS One
- Diffuse Interstitial Fibrosis and Myocardial Dysfunction in Early Chronic Kidney Disease
- (2015) Nicola C. Edwards et al. AMERICAN JOURNAL OF CARDIOLOGY
- Current MRI techniques for the assessment of renal disease
- (2015) Takamune Takahashi et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Diffusion-weighted MRI does not reflect kidney fibrosis in a rat model of fibrosis
- (2015) Peter Boor et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides
- (2015) J. P. Schanstra et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy
- (2015) Federica Genovese et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases
- (2015) Marios Papasotiriou et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Assessment of renal fibrosis in chronic kidney disease using diffusion-weighted MRI
- (2014) J. Zhao et al. CLINICAL RADIOLOGY
- Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C
- (2014) Mette J. Nielsen et al. LIVER INTERNATIONAL
- Drug discovery in renal disease—towards a more efficient framework
- (2014) Toshio Miyata et al. Nature Reviews Nephrology
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- The natural history of, and risk factors for, progressive Chronic Kidney Disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol
- (2013) Stephanie Stringer et al. BMC Nephrology
- Risk Stratification of Patients With IgA Nephropathy
- (2012) Sean J. Barbour et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Cellular and molecular mechanisms of renal fibrosis
- (2011) Youhua Liu Nature Reviews Nephrology
- A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen
- (2010) N. Barascuk et al. CLINICAL BIOCHEMISTRY
- Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
- (2010) David M. Good et al. MOLECULAR & CELLULAR PROTEOMICS
- Renal fibrosis: novel insights into mechanisms and therapeutic targets
- (2010) Peter Boor et al. Nature Reviews Nephrology
- Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease?
- (2008) Colin A Hutchison et al. EXPERT OPINION ON THERAPEUTIC TARGETS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started